Irinotecan Hydrochloride - Irinotecan Hydrochloride
Navigation: NDC > Supplier starting with: T > TEVA PARENTERAL MEDICINES, INC.| Field | Value |
|---|---|
| NDC Code: | 0703-4434 |
| Proprietary Name: | Irinotecan Hydrochloride |
| Suffix: | |
| Non-Proprietary Name: | Irinotecan Hydrochloride |
| Dosage Form: | INJECTION, SOLUTION |
| Method: | INTRAVENOUS |
| Original Marketing Date: | 27-02-2008 |
| Category Name: | ANDA |
| Application Number: | ANDA090101 |
| Labeler: | TEVA PARENTERAL MEDICINES, INC. |
| Substance Name: | IRINOTECAN HYDROCHLORIDE |
| Active Numerator Strength: | 100 |
| Active Ingredient Unit: | mg/5mL |
| Pharm Classes: | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
| DEA Schedule: |